Pepcid as a virus remedy? Trump admin’s $21M gamble fizzled


This June 15, 2020 photo shows a bottle and tablets of Pepcid antacid in Washington. The U.S. government’s Pepcid project has revealed what critics describe as the Trump administration’s disregard for science and anti-corruption rules meant to guard against taxpayer dollars going to political cronies or funding projects that aren’t rigorously designed. (AP Photo/Patrick Semansky)

WASHINGTON (AP) ─ The Trump Administration pushed through a $21 million contract to study whether the active ingredient in Pepcid is an effective treatment for COVID-19.

The Food and Drug Administration gave the clinical trial speedy approval even as a top agency official worried that daily injections of high doses of famotidine for already sick patients pushed the levels of what was considered safe “to the limits,” internal government emails show.

That contract is now under scrutiny after a government whistleblower accused a senior administration official of rushing the deal through without the scientific oversight necessary for such a large federal award.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Download Mobile Apps from WPRI 12
DOWNLOAD APPS NOW: Apple App Store | Google Play Store

Coronavirus: Complete Coverage

More Coronavirus

Dan Yorke State of Mind: Dan's Daily Update

DYSOM 1/14/2021: Richard Arenberg, Interim Director of the Taubman Center, Brown University

More Dan Yorke State of Mind

Don't Miss

Viewer Pa on


More Live Cams